Correction to: Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials.

Muralidharan, Kumar Kandadi; Kowalski, Kenneth G; Tong, Xiao; Haeberlein, Samantha Budd; Rajagovindan, Rajasimhan; Nestoro, Ivan

Muralidharan, Kumar Kandadi; Kowalski, Kenneth G; Tong, Xiao; Haeberlein, Samantha Budd; Rajagovindan, Rajasimhan; Nestoro, Ivan.

Afiliação

Muralidharan KK; Clinical Pharmacology and Pharmacometrics, Biogen, 225 Binney Street, Cambridge, MA, USA. bharathkumar.kandadimuralidharan@biogen.com.
Kowalski KG; Kowalski PMetrics Consulting, LLC, 44569 Larchwood Drive, Northville, MI, USA.
Tong X; Clinical Pharmacology and Pharmacometrics, Biogen, 225 Binney Street, Cambridge, MA, USA.
Haeberlein SB; Clinical Development, Biogen, 225 Binney Street, Cambridge, MA, USA.
Rajagovindan R; Development Imaging, Biogen, 225 Binney Street, Cambridge, MA, USA.
Nestoro I; Clinical Pharmacology and Pharmacometrics, Biogen, 225 Binney Street, Cambridge, MA, USA.

J Pharmacokinet Pharmacodyn ; 50(2): 145, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36870006

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article